Publication Information

{'id': 'https://openalex.org/W2017497567', 'doi': 'https://doi.org/10.1002/ejlt.201100117', 'title': 'Lipidomics: What does the future hold?', 'display_name': 'Lipidomics: What does the future hold?', 'publication_year': 2011, 'publication_date': '2011-05-01', 'ids': {'openalex': 'https://openalex.org/W2017497567', 'doi': 'https://doi.org/10.1002/ejlt.201100117', 'mag': '2017497567'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/ejlt.201100117', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejlt.201100117', 'source': {'id': 'https://openalex.org/S106501229', 'display_name': 'European Journal of Lipid Science and Technology', 'issn_l': '1438-7697', 'issn': ['1438-7697', '1438-9312'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejlt.201100117', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5005286924', 'display_name': 'Anna Nicolaou', 'orcid': 'https://orcid.org/0000-0002-1314-413X'}, 'institutions': [{'id': 'https://openalex.org/I139894009', 'display_name': 'University of Bradford', 'ror': 'https://ror.org/00vs8d940', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I139894009']}], 'countries': ['GB'], 'is_corresponding': True, 'raw_author_name': 'Anna Nicolaou', 'raw_affiliation_strings': ['School of Pharmacy, University of Bradford Bradford, UK.'], 'affiliations': [{'raw_affiliation_string': 'School of Pharmacy, University of Bradford Bradford, UK.', 'institution_ids': ['https://openalex.org/I139894009']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5005286924'], 'corresponding_institution_ids': ['https://openalex.org/I139894009'], 'apc_list': {'value': 4020, 'currency': 'USD', 'value_usd': 4020, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 65}, 'biblio': {'volume': '113', 'issue': '5', 'first_page': '537', 'last_page': '538'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10836', 'display_name': 'Metabolomics and Mass Spectrometry Studies', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10836', 'display_name': 'Metabolomics and Mass Spectrometry Studies', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10683', 'display_name': 'Mass Spectrometry Techniques and Applications', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/1607', 'display_name': 'Spectroscopy'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}, {'id': 'https://openalex.org/T10519', 'display_name': 'Advanced Proteomics Techniques and Applications', 'score': 0.9962, 'subfield': {'id': 'https://openalex.org/subfields/1607', 'display_name': 'Spectroscopy'}, 'field': {'id': 'https://openalex.org/fields/16', 'display_name': 'Chemistry'}, 'domain': {'id': 'https://openalex.org/domains/3', 'display_name': 'Physical Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/lipidome', 'display_name': 'Lipidome', 'score': 0.9474009}], 'concepts': [{'id': 'https://openalex.org/C58017582', 'wikidata': 'https://www.wikidata.org/wiki/Q6556376', 'display_name': 'Lipidomics', 'level': 2, 'score': 0.99396396}, {'id': 'https://openalex.org/C2780241833', 'wikidata': 'https://www.wikidata.org/wiki/Q6556375', 'display_name': 'Lipidome', 'level': 3, 'score': 0.9474009}, {'id': 'https://openalex.org/C70721500', 'wikidata': 'https://www.wikidata.org/wiki/Q177005', 'display_name': 'Computational biology', 'level': 1, 'score': 0.5605649}, {'id': 'https://openalex.org/C2522767166', 'wikidata': 'https://www.wikidata.org/wiki/Q2374463', 'display_name': 'Data science', 'level': 1, 'score': 0.4402077}, {'id': 'https://openalex.org/C41008148', 'wikidata': 'https://www.wikidata.org/wiki/Q21198', 'display_name': 'Computer science', 'level': 0, 'score': 0.3507766}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.32163334}, {'id': 'https://openalex.org/C60644358', 'wikidata': 'https://www.wikidata.org/wiki/Q128570', 'display_name': 'Bioinformatics', 'level': 1, 'score': 0.2958983}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/ejlt.201100117', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejlt.201100117', 'source': {'id': 'https://openalex.org/S106501229', 'display_name': 'European Journal of Lipid Science and Technology', 'issn_l': '1438-7697', 'issn': ['1438-7697', '1438-9312'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1002/ejlt.201100117', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ejlt.201100117', 'source': {'id': 'https://openalex.org/S106501229', 'display_name': 'European Journal of Lipid Science and Technology', 'issn_l': '1438-7697', 'issn': ['1438-7697', '1438-9312'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 4, 'referenced_works': ['https://openalex.org/W2024341695', 'https://openalex.org/W2081934181', 'https://openalex.org/W2087082980', 'https://openalex.org/W2106415248'], 'related_works': ['https://openalex.org/W4317479263', 'https://openalex.org/W3209610556', 'https://openalex.org/W3207725197', 'https://openalex.org/W2986402841', 'https://openalex.org/W2768723747', 'https://openalex.org/W2746999282', 'https://openalex.org/W2732317838', 'https://openalex.org/W2091512523', 'https://openalex.org/W1995155492', 'https://openalex.org/W1988727893'], 'abstract_inverted_index': {'The': [0, 264], 'area': [1, 458, 648, 661], 'of': [2, 12, 37, 90, 108, 124, 186, 205, 306, 371, 388, 394, 430, 444, 450, 467, 476, 479, 489, 499, 504, 514, 522, 557, 578, 587, 607, 635, 649, 662, 696, 713, 788, 814, 850, 866, 901], 'lipidomics': [3, 25, 42, 152, 225, 424, 473, 794, 841, 902], 'is': [4, 120, 176, 215, 252, 266, 295, 425, 460, 533, 573, 658, 665, 693, 755, 831, 838, 842, 853, 863, 897], 'relatively': [5, 277], 'new:': [6], 'although': [7, 330], 'publications': [8, 431, 654], 'on': [9, 132, 261, 417, 432, 710], 'MS-based': [10], 'analysis': [11, 172, 325, 643], 'cellular': [13, 247], 'lipids': [14, 133, 483], 'started': [15, 412, 744], 'to': [16, 86, 156, 166, 170, 233, 239, 268, 275, 298, 344, 378, 383, 413, 462, 541, 552, 667, 682, 707, 723, 745, 763, 784, 793, 799, 803, 810, 834], 'emerge': [17], 'in': [18, 27, 30, 33, 59, 62, 99, 111, 368, 380, 454, 526, 549, 561, 597, 726, 795, 819, 847, 858, 909], 'the': [19, 22, 28, 34, 71, 88, 106, 116, 125, 149, 177, 193, 240, 304, 369, 385, 392, 405, 418, 428, 445, 468, 477, 517, 520, 555, 576, 585, 604, 694, 711, 770, 786, 844, 898], 'early': [20], '1990s,': [21], 'actual': [23, 899], 'term': [24], 'appeared': [26], 'literature': [29], '2003.': [31], 'However,': [32], 'short': [35], 'space': [36], 'less': [38], 'than': [39, 227], '10': [40], 'years,': [41], 'has': [43, 221, 801], 'emerged': [44], 'as': [45, 139, 290, 404, 669], 'an': [46, 121, 249, 287, 366, 381, 415, 457, 632, 646, 659], 'extremely': [47], 'valuable': [48, 168], 'tool': [49], 'for': [50, 198, 303, 312, 323, 354, 423, 616, 621, 733, 758, 773], 'biosciences': [51], '1-4.': [52], 'Large': [53], 'research': [54, 663, 790, 851], 'networks': [55, 110], '(e.g.': [56], 'LIPID': [57], 'MAPS': [58], 'USA,': [60], 'LipidomicsNet': [61], 'Europe,': [63], 'etc.),': [64], 'smaller': [65], 'consortia': [66, 742], 'and': [67, 81, 95, 98, 113, 134, 136, 144, 164, 173, 183, 190, 203, 223, 337, 358, 400, 448, 507, 582, 644, 678, 686, 704, 717, 730, 737, 760, 805, 816, 826, 852, 860, 907], 'specialised': [68], 'laboratories': [69], 'around': [70, 603], 'world': [72], 'have': [73, 364, 411, 511, 702, 743], 'focused': [74], 'their': [75, 505, 747], 'effort': [76, 762], 'towards': [77, 672], 'standardising': [78], 'experimental': [79], 'protocols': [80], 'lipid': [82, 109, 171, 188, 201, 279, 433, 452, 523, 543, 558, 589, 609, 618, 881], 'nomenclature,': [83], 'whilst': [84, 391], 'attempting': [85], 'map': [87, 554], 'lipidome': [89, 712], 'model': [91], 'systems,': [92], 'cells,': [93, 715], 'tissues': [94, 716, 817], 'body': [96], 'fluids,': [97], 'this': [100, 571, 598, 657, 765], 'way': [101, 797], 'gain': [102], 'new': [103, 406, 608], 'information': [104, 709], 'into': [105, 868], 'role': [107], 'health': [112], 'disease.': [114], 'At': [115], 'same': [117], 'time': [118, 700], 'there': [119, 532, 600, 754], 'increased': [122], 'awareness': [123], 'field': [126], 'with': [127, 396, 624, 651], 'more': [128, 226], 'conferences': [129], 'organising': [130], 'sessions': [131], 'lipidomics,': [135, 676], 'societies': [137], 'such': [138, 313, 403], 'EuroFedLipid,': [140], 'forming': [141], 'interest': [142], 'groups': [143], 'divisions.': [145], 'We': [146], 'cannot': [147], 'dispute': [148], 'fact': [150], 'that': [151, 180, 207, 217, 251, 319, 352, 459, 638, 656, 664, 840, 895, 903], 'owes': [153], 'its': [154, 480], 'existence': [155], 'modern': [157], 'MS.': [158], 'Although': [159, 740, 829], 'other': [160, 229], 'technologies': [161, 884], 'are': [162, 320, 342, 484, 496, 547, 601], 'relevant': [163], 'continue': [165, 706], 'offer': [167], 'service': [169], 'biology,': [174], 'MS': [175, 235, 379], 'primary': [178], 'methodology': [179], 'allows': [181], 'qualitative': [182], 'quantitative': [184, 324, 356], 'assessment': [185], 'multiple': [187, 327, 874], 'species,': [189], 'can': [191, 630], 'generate': [192, 463, 631, 708, 905], 'large': [194, 789], 'data': [195, 243, 636, 642, 721, 748], 'sets': [196, 244], 'needed': [197], 'mapping': [199], 'complex': [200], 'associations': [202], 'exploration': [204], 'interactions': [206], 'characterise': [208], 'biological': [209, 529], '‘omics’': [210], 'approaches.': [211, 309], 'Looking': [212], 'back,': [213], 'it': [214, 830, 837, 896], 'evident': [216, 839], 'electrospray': [218], 'ionisation': [219, 439], '(ESI)': [220], 'influenced': [222], 'shaped': [224], 'any': [228, 282, 527], 'technique.': [230], 'When': [231], 'coupled': [232, 297, 343, 377], 'tandem': [234], '(MS/MS),': [236], 'ESI-MS/MS': [237], 'led': [238], 'first': [241], 'lipidomic': [242, 389, 628, 697, 812], 'obtained': [245], 'from': [246, 779], 'phospholipids,': [248], 'approach': [250, 288], 'now': [253], 'widely': [254], 'employed': [255], 'by': [256, 333, 427, 472, 584, 612, 879], 'almost': [257], 'all': [258, 542, 877], 'labs': [259], 'working': [260], 'membrane': [262], 'lipids.': [263], 'system': [265], 'applicable': [267, 540], 'direct': [269], 'infusion': [270], 'or': [271, 285, 348, 493, 537, 593], 'gunshot': [272], 'experiments': [273], 'used': [274, 311, 818], 'analyse': [276], 'crude': [278], 'extracts': [280], 'without': [281], 'prior': [283], 'separation': [284], 'purification,': [286], 'described': [289], 'global': [291], 'lipidomics.': [292, 595, 613], 'Furthermore,': [293, 531], 'ESI': [294], 'easily': [296], 'liquid': [299, 374], 'chromatography': [300, 375], '(LC)': [301], 'allowing': [302], 'development': [305, 577, 825], 'LC-MS/MS-based': [307], 'targeted': [308, 579], 'Spectrometers': [310], 'applications': [314], 'include': [315], 'triple': [316], 'quadrupoles': [317, 341], '(Q3)': [318], 'particularly': [321], 'good': [322], 'through': [326, 575, 750], 'reaction': [328], 'monitoring,': [329], 'generally': [331], 'characterised': [332, 878], 'low': [334], 'mass': [335, 360, 398], 'resolution,': [336], 'hybrid': [338], 'systems': [339, 684, 687, 820], 'where': [340], 'ion': [345, 408], 'traps': [346], '(Q-Trap)': [347], 'time-of-flight': [349], '(Q-TOF)': [350], 'analysers': [351], 'allow': [353], 'both': [355], 'approaches': [357, 580, 629, 674], 'high': [359, 397], 'accuracy.': [361], 'Recently,': [362], 'we': [363, 510, 546, 670, 701, 777, 782, 808], 'seen': [365], 'increase': [367, 384, 887], 'use': [370], 'ultrahigh': [372], 'performance': [373], '(UPLC)': [376], 'attempt': [382], 'high-through-put': [386], 'efficiency': [387], 'analyses,': [390], 'availability': [393], 'spectrometers': [395], 'accuracy': [399], 'resolving': [401], 'power,': [402], 'linear': [407], 'trap-Orbitrap': [409], 'instruments,': [410], 'make': [414, 746, 835], 'impact': [416, 857], 'field.': [419], 'Another': [420, 690], 'emerging': [421], 'direction': [422], 'marked': [426], 'appearance': [429], 'imaging': [434], 'using': [435], 'matrix-assisted': [436], 'laser': [437], 'desorption': [438], '(MALDI).': [440], 'MALDI-TOF': [441], 'permits': [442], 'identification': [443], 'spatial': [446], 'distribution': [447], 'localisation': [449], 'various': [451, 714], 'species': [453, 524, 559, 610], 'tissue': [455], 'slices,': [456], 'anticipated': [461], 'exciting': [464], 'findings.': [465], 'Some': [466], 'main': [469], 'challenges': [470], 'faced': [471], 'stem': [474], 'out': [475], 'nature': [478], 'subject': [481], 'matter:': [482], 'not': [485, 497, 832], 'a': [486, 562, 727, 796, 855], 'uniform': [487, 568], 'class': [488], 'compounds;': [490], 'unlike': [491], 'genes': [492], 'proteins,': [494], 'they': [495], 'composed': [498], 'similar': [500, 798], 'units': [501, 791], 'and,': [502], 'because': [503], 'structural': [506], 'chemical': [508], 'diversity,': [509], 'no': [512, 534], 'means': [513], 'predicting': [515], 'neither': [516], 'type': [518], 'nor': [519], 'number': [521, 634], 'present': [525, 560], 'given': [528], 'system.': [530], 'single': [535, 567], 'extraction': [536], 'analytical': [538, 889], 'protocol': [539], 'classes,': [544, 590], 'consequently': [545], 'restricted': [548], 'our': [550, 888], 'ability': [551], 'reliably': [553], 'thousands': [556], 'particular': [563], 'sample,': [564], 'following': [565], 'one': [566], 'approach.': [569], 'Currently,': [570], 'problem': [572], 'addressed': [574], 'informed': [581], 'directed': [583], 'properties': [586], 'individual': [588], 'e.g.': [591], 'sphingolipid': [592], 'eicosanoid': [594], 'Even': [596], 'case,': [599], 'issues': [602], 'accurate': [605], 'quantitation': [606], 'identified': [611], 'This': [614, 720], 'need': [615, 722, 757], 'synthetic': [617], 'standards': [619], 'calls': [620], 'close': [622], 'collaboration': [623], 'organic': [625], 'chemists.': [626], 'Global': [627], 'overwhelming': [633], 'points': [637], 'require': [639], 'computer': [640], 'assisted': [641], 'management,': [645], 'obvious': [647], 'interaction': [650], 'bioinformatics.': [652], 'Recent': [653], 'indicate': [655], 'active': [660], 'expected': [666], 'expand': [668], 'move': [671], 'integrated': [673], 'including': [675], 'transcriptomics': [677], 'proteomics,': [679], 'brought': [680], 'together': [681], 'address': [683], 'biology': [685, 859], 'medicine': [688], 'applications.': [689], 'important': [691], 'issue': [692], 'curation': [695], 'data:': [698], 'over': [699], 'gathered': [703], 'will': [705, 885, 904], 'clinical': [718], 'samples.': [719], 'be': [724], 'collected': [725], 'coherent': [728], 'manner': [729], 'made': [731], 'available': [732, 749], 'meta-analysis,': [734], 'comparative': [735], 'studies': [736, 867], 'further': [738], 'research.': [739], 'some': [741], 'dedicated': [751, 792], 'web': [752], 'sites,': [753], 'strong': [756, 856], 'organised': [759], 'sustained': [761], 'capture': [764], 'activity.': [766], 'So,': [767], 'what': [768, 800], 'does': [769], 'future': [771], 'hold': [772], 'lipidomics?': [774], 'Where': [775], 'do': [776], 'go': [778], 'here?': [780], 'Are': [781, 807], 'going': [783, 809], 'see': [785, 811], 'formation': [787], 'happened': [802], 'proteomics': [804], 'genomics?': [806], 'maps': [813], 'cells': [815], 'medicine,': [821], 'biomarker': [822], 'discovery,': [823], 'drug': [824], 'personalised': [827], 'treatment?': [828], 'easy': [833], 'predictions,': [836], 'influencing': [843], 'current': [845], 'thinking': [846], 'many': [848], 'fields': [849], 'making': [854], 'medicine.': [861], 'Lipidomics': [862], 'already': [864], 'part': [865], 'cardiovascular': [869], 'disease,': [870], 'diabetes,': [871], 'brain': [872], 'disorders,': [873], 'sclerosis,': [875], 'obesity,': [876], 'altered': [880], 'biochemistry.': [882], 'New': [883], 'undoubtedly': [886], 'capabilities,': [890], 'but,': [891], 'I': [892], 'strongly': [893], 'believe': [894], 'application': [900], 'breakthroughs': [906], 'innovation': [908], 'biosciences.': [910]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2017497567', 'counts_by_year': [], 'updated_date': '2024-12-09T03:39:31.188797', 'created_date': '2016-06-24'}